News
Some experts say oral versions of popular weight-loss drugs such as Wegovy could offer people more flexibility and ...
Pediatric patients with short bowel syndrome‐associated intestinal failure showed improvements in stool consistency and ...
2d
GlobalData on MSNTNF and Renova Health use AI to identify patients for GLP-1 treatmentsTNF Pharmaceuticals and Renova Health are set to use AI and machine learning for the identification of high-risk subjects who ...
ProFuse's novel technology addresses the growing need to preserve muscle in the face of aging and the popularity of ...
4d
Discover Magazine on MSNExercising Your Body and Mind Could Help Stop Dementia Before it StartsDiscover more ways to keep your body and mind healthy and strong against dementia.
The rapid increase in the use of glucagon-like peptide-1 receptor agonists for weight loss, diabetes management and ...
Conduct CT in India: CDSCO Panel tells Novo Nordisk India For new formulation of Semaglutide tablets
The committee noted that semaglutide tablets 3 mg, 7 mg, and 14 mg are approved for marketing in India. The firm has claimed ...
A new expert review endorses GLP-1 RAs and other medications for sustainable weight loss in children with obesity and MASLD.
CMS clawed back $13.2 million in money improperly sent to Molina Healthcare as a result of the what the Justice Department alleges were unlawful actions by insurance brokers.
Short term trials with surrogate measures instead of hard outcomes are often used to study chronic diseases. The effects of an intervention may, however, take time to develop and persist after ...
A new study into GLP-1RA drugs provides previously unknown insights into the impact this class of drugs may have on eating ...
The research sheds new light on how this enzyme influences glucagon secretion in pancreatic alpha (α) cells, a process crucial for maintaining healthy blood sugar levels. The research ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results